dc.creator | Zobrist, Stephanie | |
dc.creator | Oliveira-Silva, Michelle | |
dc.creator | Vieira, Alexia Martines | |
dc.creator | Bansil, Pooja | |
dc.creator | Gerth-Guyette, Emily | |
dc.creator | Leader, Brandon T. | |
dc.creator | Golden, Allison | |
dc.creator | Slater, Hannah | |
dc.creator | Cruz, Catherine Duran de Lucena | |
dc.creator | Garbin, Eduardo | |
dc.creator | Sagalovsky, Mariana | |
dc.creator | Pal, Sampa | |
dc.creator | Gupta, Vin | |
dc.creator | Wolansky, Leo | |
dc.creator | Dall'Acqua, Deusilene Souza Vieira | |
dc.creator | Naveca, Felipe Gomes | |
dc.creator | Nascimento, Valdinete Alves do | |
dc.creator | Villalobos Salcedo, Juan Miguel | |
dc.creator | Drain, Paul K. | |
dc.creator | Costa, Alexandre Dias Tavares | |
dc.creator | Domingo, Gonzalo J. | |
dc.creator | Pereira, Dhélio | |
dc.date | 2022-06-20T18:54:40Z | |
dc.date | 2022-06-20T18:54:40Z | |
dc.date | 2022 | |
dc.date.accessioned | 2023-09-26T22:31:45Z | |
dc.date.available | 2023-09-26T22:31:45Z | |
dc.identifier | ZOBRIST, Stephanie et al. Screening for severe acute respiratory syndrome coronavirus 2 in close contacts of individuals with confirmed infection: performance and operational considerations. The Journal of Infectious Diseases, p. 1-11, 20 May 2022. | |
dc.identifier | 0022-1899 | |
dc.identifier | https://www.arca.fiocruz.br/handle/icict/53379 | |
dc.identifier | 10.1093/infdis/jiac204 | |
dc.identifier | 1537-6613 | |
dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/8880383 | |
dc.description | Background. Point-of-care and decentralized testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is critical to inform public health responses. Performance evaluations in priority use cases such as contact tracing can highlight trade-offs in test selection and testing strategies. Methods. A prospective diagnostic accuracy study was conducted among close contacts of coronavirus disease 2019 (COVID19) cases in Brazil. Two anterior nares swabs (ANS), a nasopharyngeal swab (NPS), and saliva were collected at all visits. Vaccination history and symptoms were assessed. Household contacts were followed longitudinally. Three rapid antigen tests and 1 molecular method were evaluated for usability and performance against reference reverse-transcription polymerase chain reaction (RT-PCR) on nasopharyngeal swab specimens. Results. Fifty index cases and 214 contacts (64 household) were enrolled. Sixty-five contacts were RT-PCR positive during ≥1 visit. Vaccination did not influence viral load. Gamma variants were most prevalent; Delta variants emerged increasingly during implementation. The overall sensitivity of evaluated tests ranged from 33% to 76%. Performance was higher among symptomatic cases and those with cycle threshold (Ct) values ,34 and lower among oligosymptomatic or asymptomatic cases. Assuming a 24-hour time to results for RT-PCR, the cumulative sensitivity of an anterior nares swab rapid antigen test was .70% and almost 90% after 4 days. Conclusions. The near-immediate time to results for antigen tests significantly offsets lower analytical sensitivity in settings where RT-PCR results are delayed or unavailable. | |
dc.format | application/pdf | |
dc.language | eng | |
dc.publisher | Oxford University Press | |
dc.rights | open access | |
dc.subject | Porto Velho | |
dc.subject | Rondônia | |
dc.subject | Allplex SARS-CoV-2 assay | |
dc.subject | SalivaDirect | |
dc.subject | Teste PADRÃO Q COVID-19 Ag | |
dc.subject | LumiraDx SARS-CoV-2 Ag test | |
dc.subject | Porto Velho | |
dc.subject | Rondônia | |
dc.subject | Allplex SARS-CoV-2 assay | |
dc.subject | SalivaDirect | |
dc.subject | SD Biosensor STANDARD Q COVID-19 Ag | |
dc.subject | LumiraDx SARS-CoV-2 Ag test | |
dc.subject | Porto Velho | |
dc.subject | Rondônia | |
dc.subject | Ensayo Allplex SARS-CoV-2 | |
dc.subject | SalivaDirect | |
dc.subject | SD Biosensor STANDARD Q COVID-19 Ag | |
dc.subject | La Prueba LumiraDx SARS-CoV-2 Ag | |
dc.subject | SARS-CoV-2 | |
dc.subject | COVID-19 | |
dc.subject | Reação em Cadeia da Polimerase Via Transcriptase Reversa | |
dc.subject | Kit de Reagentes para Diagnóstico | |
dc.title | Screening for severe acute respiratory syndrome coronavirus 2 in close contacts of individuals with confirmed infection: performance and operational considerations | |
dc.type | Article | |